ENvue Medical, Inc.
AI Executive Summary
AI-powered analysis of 10-Q filing content
ENvue Medical shows severe deterioration with revenue declining 36% year-over-year to $653K, negative gross margins of -8.4%, and massive preferred stock-related charges totaling $18.8M creating net loss available to common stockholders of $22.6M. Cash position weakened significantly with $2M burn in Q1 2026 leaving only $2.2M remaining.
Red Flags Detected (7)
Revenue decline of 36% year-over-year ($653K vs $1,025K)
Negative gross margin of -8.4% ($55K gross loss)
Massive deemed dividend charges totaling $18.8M on preferred stock
4 more red flags detected
Key Takeaways
Company faces immediate financial distress with negative gross margins and rapid cash depletion
Complex preferred stock structure created massive dilutive impact on common shareholders
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.